Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Peters Medical Research
321
mi
from 43215
HIgh Point, NC
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Peters Medical Research
321
mi
from 43215
HIgh Point, NC
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated:  6/28/2012
Altoona Center for Clinical Research
243
mi
from 43215
, PA
D-Ribose for Fatigue in Subjects With Fibromyalgia
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of D-Ribose in Subjects With Fibromyalgia
Status: Enrolling
Updated: 6/28/2012
Altoona Center for Clinical Research
243
mi
from 43215
, PA
Click here to add this to my saved trials
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated:  8/14/2012
East Tennessee State University
254
mi
from 43215
Johnson City, TN
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Quetiapine Compared With Placebo in the Management of Fibromyalgia
Status: Enrolling
Updated: 8/14/2012
East Tennessee State University
254
mi
from 43215
Johnson City, TN
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 010
497
mi
from 43215
Birmingham, AL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 010
497
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 064
1987
mi
from 43215
Fresno, CA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 064
1987
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 009
1959
mi
from 43215
Orange, CA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 009
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site
2042
mi
from 43215
Sacramento, CA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 077
1161
mi
from 43215
Colorado Springs, CO
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 077
1161
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site
553
mi
from 43215
Cromwell, CT
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site
553
mi
from 43215
Cromwell, CT
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 041
767
mi
from 43215
Orange City, FL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 041
767
mi
from 43215
Orange City, FL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 061
796
mi
from 43215
Orlando, FL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 061
796
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 014
792
mi
from 43215
Spring Hill, FL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 014
792
mi
from 43215
Spring Hill, FL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 032
931
mi
from 43215
West Palm Beach, FL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 032
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 1080
360
mi
from 43215
Blue Ridge, GA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 1080
360
mi
from 43215
Blue Ridge, GA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 1332
555
mi
from 43215
Savannah, GA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 1332
555
mi
from 43215
Savannah, GA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 1869
349
mi
from 43215
Peoria, IL
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 1869
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 087
189
mi
from 43215
Louisville, KY
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 087
189
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 1892
167
mi
from 43215
Ann Arbor, MI
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 1892
167
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 1342
230
mi
from 43215
Stevensville, MI
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 1342
230
mi
from 43215
Stevensville, MI
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 049
437
mi
from 43215
Whitehouse Station, NJ
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 049
437
mi
from 43215
Whitehouse Station, NJ
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site
371
mi
from 43215
Raleigh, NC
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 022
307
mi
from 43215
Winston-Salem, NC
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 022
307
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 122
110
mi
from 43215
Akron, OH
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 122
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 005
98
mi
from 43215
Cincinnati, OH
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 005
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 026
65
mi
from 43215
Dayton, OH
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 026
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site
849
mi
from 43215
Oklahoma City, OK
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 066
144
mi
from 43215
Mechanicsburg, PA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 066
144
mi
from 43215
Mechanicsburg, PA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 019
412
mi
from 43215
Philadelphia, PA
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 019
412
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 048
350
mi
from 43215
Greer, SC
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 048
350
mi
from 43215
Greer, SC
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 062
1138
mi
from 43215
San Antonio, TX
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 062
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 014
1519
mi
from 43215
Clinton, UT
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 014
1519
mi
from 43215
Clinton, UT
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative site 100
1510
mi
from 43215
Salt Lake City, UT
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative site 100
1510
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated:  8/23/2012
Forest Investigative Site 004
311
mi
from 43215
Racine, WI
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Status: Enrolling
Updated: 8/23/2012
Forest Investigative Site 004
311
mi
from 43215
Racine, WI
Click here to add this to my saved trials
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
Urocortins and Musculoskeletal Hyperalgesia
Status: Enrolling
Updated:  10/22/2012
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
Urocortins and Musculoskeletal Hyperalgesia
Status: Enrolling
Updated: 10/22/2012
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
mi
from 43215
Birmingham, AL
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
mi
from 43215
Sacramento, CA
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
mi
from 43215
Jacksonville, FL
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
mi
from 43215
Evansville, IN
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
mi
from 43215
Ann Arbor, MI
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
375
mi
from 43215
Raleigh, NC
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
375
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
2060
mi
from 43215
Medford, OR
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
2060
mi
from 43215
Medford, OR
Click here to add this to my saved trials
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated:  5/11/2013
IMC Study Site
1513
mi
from 43215
Salt Lake City, UT
A Study of IMC-1 In Patients With Fibromyalgia
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 5/11/2013
IMC Study Site
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Effect of Milnacipran on Pain in Fibromyalgia
Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study
Status: Enrolling
Updated:  6/24/2013
UCSD Medical Center, La Jolla
1953
mi
from 43215
San Diego, CA
Effect of Milnacipran on Pain in Fibromyalgia
Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study
Status: Enrolling
Updated: 6/24/2013
UCSD Medical Center, La Jolla
1953
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Genova Clinical Research
1640
mi
from 43215
Tucson, AZ
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Genova Clinical Research
1640
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Osteoporosis Medical Center
mi
from 43215
Beverly Hills, CA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Osteoporosis Medical Center
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
SDS Clinical Trials
1959
mi
from 43215
Orange, CA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
SDS Clinical Trials
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Research Across America
1960
mi
from 43215
Santa Ana, CA
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Research Across America
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Innovative Research of West Florida, Inc.
830
mi
from 43215
Clearwater, FL
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Innovative Research of West Florida, Inc.
830
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated:  7/16/2013
Florida Medical Center & Research, Inc.
mi
from 43215
Coral Gables, FL
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Florida Medical Center & Research, Inc.
mi
from 43215
Coral Gables, FL
Click here to add this to my saved trials